4D Molecular Therapeutics, Inc. - Demonstração de Resultados (TTM)

4D Molecular Therapeutics, Inc.
US ˙ NasdaqGS ˙ US35104E1001

Demonstração de Resultados (TTM)

A Demonstração de Resultados de 4D Molecular Therapeutics, Inc. mostra mudanças na receita e despesas ao longo de um período de tempo. Os dados da Demonstração de Resultados incluem Vendas e Receita, Lucro Bruto, Pesquisa e Desenvolvimento (P&D), Despesas de Vendas, Gerais e Administrativas (SG&A), Renda Operacional, Despesa com Imposto de Renda, Despesa com Juros, Renda Não Operacional, Lucro por Ação (EPS) e Ações em Circulação.

Todos os números são vezes 1,000,000 exceto unidades por ação.

2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
2025
09-30
2025
12-31
2026
03-31
Receita 23 17 18 17 3 2 3 2 2 22 21 20 20 0 0 0 0 0 85 88
Mudar (%) -26.30 6.30 -4.33 -83.54 -30.49 58.51 -29.43 3.49 862.32 -5.76 -1.30 -1.15 -99.92 117.65 -37.84 43.48 263.64 70,907.50 3.56
% da receita 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Custo das vendas 52 56 61 68 73 76 80 83 86 93 97 103 111 124 141 154 170 178 192 217
Mudar (%) 8.22 8.72 10.78 7.67 4.23 5.21 3.78 3.78 7.09 4.89 5.62 8.06 12.11 13.73 9.08 10.44 4.61 8.10 12.61
% da receita 226.51 332.59 340.17 393.88 2,577.01 3,864.29 2,564.81 3,771.92 3,782.76 420.97 468.54 501.41 548.13 730,823.53 381,889.19 670,121.74 515,824.24 148,395.83 225.91 245.66
Lucro Operacional Bruto -29 -39 -43 -51 -70 -74 -77 -81 -84 -71 -76 -82 -91 -124 -141 -154 -170 -178 -107 -129
Mudar (%) 35.50 9.76 17.07 38.71 5.63 3.79 5.12 3.79 -16.13 8.21 7.50 10.36 37.11 13.72 9.09 10.44 4.56 -39.71 19.80
% da receita -126.51 -232.59 -240.17 -293.88 -2,477.01 -3,764.29 -2,464.81 -3,671.92 -3,682.76 -320.97 -368.54 -401.41 -448.13 -730,723.53 -381,789.19 -670,021.74 -515,724.24 -148,295.83 -125.91 -145.66
Vendas, Gerais e Administrativas 23 28 28 31 32 32 33 33 33 34 36 39 41 44 47 49 50 49 49 48
Mudar (%) 19.57 1.77 9.59 3.90 -0.40 3.59 -0.72 1.94 3.16 6.22 6.31 4.69 8.71 5.49 5.67 1.86 -1.62 -0.54 -2.55
% da receita 99.97 162.20 155.29 177.89 1,123.10 1,609.37 1,051.71 1,479.62 1,457.51 156.24 176.10 189.68 200.89 259,723.53 125,889.19 214,004.35 151,930.30 41,103.33 57.58 54.18
P&D
Mudar (%)
% da receita
OpEx 75 84 89 99 105 108 113 116 120 127 134 141 151 168 188 203 220 227 242 265
Mudar (%) 11.69 6.44 10.40 6.50 2.82 4.73 2.47 3.27 6.00 5.25 5.81 7.14 11.20 11.57 8.23 8.36 3.19 6.23 9.53
% da receita 326.49 494.78 495.46 571.77 3,700.11 5,473.66 3,616.52 5,251.54 5,240.26 577.22 644.65 691.10 749.02 990,547.06 507,778.38 884,126.09 667,754.55 189,499.17 283.49 299.84
Lucro operacional -52 -67 -71 -81 -102 -106 -110 -114 -117 -105 -113 -121 -131 -168 -188 -203 -220 -227 -156 -176
Mudar (%) 28.47 6.48 14.13 25.59 3.75 3.73 3.38 3.26 -10.66 7.56 7.11 8.54 28.32 11.56 8.24 8.36 3.16 -31.21 12.79
% da receita -226.49 -394.78 -395.46 -471.77 -3,600.11 -5,373.66 -3,516.52 -5,151.54 -5,140.26 -477.22 -544.65 -591.10 -649.02 -990,447.06 -507,678.38 -884,026.09 -667,654.55 -189,399.17 -183.49 -199.84
Despesa com juros
Mudar (%)
% da receita
Resultado líquido -52 -67 -71 -81 -102 -105 -107 -110 -111 -96 -101 -105 -110 -143 -161 -176 -196 -209 -140 -161
Mudar (%) 27.51 6.79 13.93 25.23 3.39 2.18 2.18 1.39 -13.86 5.11 3.69 5.10 30.56 12.12 9.68 11.17 6.64 -33.02 14.84
% da receita -227.48 -393.55 -395.37 -470.82 -3,582.61 -5,329.18 -3,435.41 -4,974.55 -4,873.87 -436.28 -486.59 -511.20 -543.54 -844,000.00 -434,778.38 -767,126.09 -594,375.76 -174,314.17 -164.43 -182.34

Source: Capital IQ

How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista